Year
2025202420232022202120202018201720162015201420132012201120102009200820072006200520042003200220012000
Edition number
№7 / 2019 (Oncology / Surgery)
REVIEWS
T.Yu. Semiglazova (1, 2), I.V. Sorokina (3)
Prognostic and predictive values of the PIK3CA gene mutation in patients with breast cancer10-20
A.E. Zhukova, S.A. Protsenko, A.V. Novik, D.O. Yurlov
Prognostic markers for testicular germ cell tumors. Research perspectives21-26
I.A. Baldueva (1), A.V. Novik (1, 2)
The role of peripheral blood immunological parameters as predictive markers in cancer patients: the prognostic role of the neutrophil/lymphocyte ratio28-32
ORIGINAL ARTICLES
N.N. Buevich (1), S.A. Protsenko (1), A.K. Nosov (1), S.A. Reva (1, 2), A.S. Artemyeva (1), M.V. Berkut (1)
Intermediate assessment of the results of a clinical study of a neoadjuvant combined treatment of patients with high-risk and very high-risk prostate cancer33-37
N.P. Belyak (1, 2), S.I. Kutukova (1, 3), R.V. Orlova (1, 2), N.V. Zhukova (1, 2), S.P. Erdniev (1), E.Yu. Zorina (1), I.V. Avramenko (1), N.Yu. Antimonik (1), N.V. Popova (1), A.K. Ivanova (1), A.V. Androsova (1)
The use of ramukirumab in the treatment of metastatic gastric cancer in real clinical practice38-42
E.V. Bakhidze (1, 2), V.A. Belyaeva (3), A.A. Domansky (1), N.A. Mikaya (1), I.V. Berlev (1, 2)
Pharmacotherapy and surgical treatment of adult granulosa cell ovarian tumors: analysis of own and literature data43-49
P.V. Kazantseva (1), E.M. Slonimskaya (1, 2), M.M. Tsyganov (1), M.K. Ibragimova (1, 3), A.V. Doroshenko (1), N.A. Tarabanovskaya (1), N.V. Litviakov (1, 3)
Predictive and prognostic significance of stemness gene amplifications in the breast tumor in patients who received neoadjuvant chemotherapy50-56
L.Yu. Vladimirova, I.L. Popova, N.A. Abramova, A.E. Storozhakova, N.M. Tikhanovskaya, K.A. Novoselova, A.A. Lyanova, L.A. Ryadinskaya, M.O. Yezhova, M.A. Teplyakov
Trastuzumab emtanzin in the treatment of HER2-positive metastatic breast cancer in patients with visceral crisis58-63
L.V. Filatova (1, 2)
Immunotherapy for classic Hodgkin’s lymphoma64-72
S.A. Protsenko (1), A.I. Semenova (1), A.P. Oganesyan (1), E.M. Anokhina (1), A.V. Novik (1, 2)
Modern immunotherapy for kidney cancer73-78
K.O. Kondratieva, M.V. Vagaytseva, T.Yu. Semiglazova
The role of the medical psychologist in the multidisciplinary team for the rehabilitation of cancer patients79-81
V.S. Fomin, V.N. Yakovenko
Resonance electrostimulation in the treatment of postoperative motor-evacuation disorders: theoretical rationale and therapeutic algorithm of application82-87
N.V. Zhukova (1, 2), R.V. Orlova (1, 2), N.Yu. Antimonik (1), S.I. Kutukova (1, 3), N.P. Belyak (1, 2), O.V. Vasyusina (3), N.V. Popova (1)
The effectiveness of an integrated approach to the treatment of patients with melanoma with metastatic brain lessions: clinical observation88-95
D.D. Sakaeva (1, 2), A.F. Nasretdinov (1)
Oral chemotherapy with vinorelbine for advanced breast cancer: its role in clinical practice96-101
S.A. Protsenko, G.M. Teletaeva, E.A. Degtiareva, E.V. Levchenko, N.E. Levchenko, A.V. Mishchenko, I.A. Burovik, A.S. Artemyeva, E.N. Imyanitov, A.I. Semenova, A.V. Novik, D.Kh. Latipova
PEComas: what are the treatment options? literature review and personal experience102-107